Pemphigus

Biologics and Immunomodulators for Immunobullous Diseases
Immunobullous Diseases
by Nishad Sathe, MD on
At ODAC 2023, we had the opportunity to learn about the latest in treatments for blistering diseases from Dr. Karl Saardi, Associate Professor and Director of Inpatient Dermatology at George Washington University. We focused on the pemphigus and pemphigoid group of diseases, which we will review and summarize here. Pemphigus The pemphigus group of diseases is characterized by intraepidermal auto …
Mycophenolate Mofetil Therapeutic Cheat Sheet
Mycophenolate Mofetil
by Blair Allais, MD on
When standard treatment options fail and corticosteroids are not a long-term option, dermatologists often have to look back to their tool-kit and pull out the “big guns.” Mycophenolate mofetil has emerged as a promising immunosuppressive agent for severe immune-mediated and inflammatory dermatologic disease. We continue our series, Therapeutic Cheat Sheet, with a closer look at mycophenolate m …
Journal Review Series: January – March 2018
derm journals
by Ramya Kollipara, MD on
Derm In-Review Advisory Council Member, Dr. Ramya Kollipara, searched dermatology journals so that you don’t have to! She reports on important take-aways from different medical journals for the months of January, February, and March of 2018.  Find study tools and more like this at Derm In-Review. It is key to keep in mind that “important” is subjective and what is contained in this revie …